Search Results

Filter
  • 1-10 of  8,702 results for ""Hallucinogens""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A Brief Historical Overview of Psychedelic Research.

  • Authors : Geyer MA; UC San Diego Center for Psychedelic Research, Department of Psychiatry, School of Medicine, University of California San Diego, La Jolla, California. Electronic address: .

Subjects: Hallucinogens*/Hallucinogens*/Hallucinogens*/pharmacology ; Hallucinogens*/Hallucinogens*/Hallucinogens*/history; Humans

  • Source: Biological psychiatry. Cognitive neuroscience and neuroimaging [Biol Psychiatry Cogn Neurosci Neuroimaging] 2024 May; Vol. 9 (5), pp. 464-471. Date of Electronic Publication: 2023 Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 101671285 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Therapeutic potential of psychedelics: History, advancements, and unexplored frontiers.

  • Authors : Maia JM; Department of Medicine, Federal University of Juiz de Fora, Governador Valadares, MG 35032-620, Brazil.; de Oliveira BSA

Subjects: Hallucinogens*/Hallucinogens*/Hallucinogens*/pharmacology ; Hallucinogens*/Hallucinogens*/Hallucinogens*/therapeutic use ; Behavior, Addictive*

  • Source: Progress in neuro-psychopharmacology & biological psychiatry [Prog Neuropsychopharmacol Biol Psychiatry] 2024 Apr 20; Vol. 131, pp. 110951. Date of Electronic Publication: 2024 FebPublisher: Pergamon Press Country of Publication: England NLM ID: 8211617 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety.

  • Authors : Fried EI; Department of Psychology, Clinical Psychology Unit, Leiden University, Leiden, the Netherlands.; Cristea IA

Subjects: Psilocybin*/Psilocybin*/Psilocybin*/therapeutic use ; Psilocybin*/Psilocybin*/Psilocybin*/pharmacology ; Psilocybin*/Psilocybin*/Psilocybin*/adverse effects

  • Source: JAMA psychiatry [JAMA Psychiatry] 2024 Jun 01; Vol. 81 (6), pp. 633-634.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials.

  • Authors : Soliman PS; Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA.; Department of Neuroscience, Brown University, Providence, RI, USA.

Subjects: Hallucinogens*/Hallucinogens*/Hallucinogens*/administration & dosage ; Hallucinogens*/Hallucinogens*/Hallucinogens*/pharmacology ; Randomized Controlled Trials as Topic*/Randomized Controlled Trials as Topic*/Randomized Controlled Trials as Topic*/methods

  • Source: Psychopharmacology [Psychopharmacology (Berl)] 2024 Jun; Vol. 241 (6), pp. 1101-1110. Date of Electronic Publication: 2024 Apr 29.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Adolescent Psychedelic Use and Psychotic or Manic Symptoms.

  • Authors : Simonsson O; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Mosing MA

Subjects: Hallucinogens*/Hallucinogens*/Hallucinogens*/adverse effects ; Hallucinogens*/Hallucinogens*/Hallucinogens*/administration & dosage ; Registries*

  • Source: JAMA psychiatry [JAMA Psychiatry] 2024 Jun 01; Vol. 81 (6), pp. 579-585.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Mechanisms of therapeutic change after psychedelic treatment in OCD.

  • Authors : Maloney G; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States; Perth OCD Clinic, Perth, Australia. Electronic address: .

Subjects: Hallucinogens*/Hallucinogens*/Hallucinogens*/therapeutic use ; Hallucinogens*/Hallucinogens*/Hallucinogens*/pharmacology ; Obsessive-Compulsive Disorder*/Obsessive-Compulsive Disorder*/Obsessive-Compulsive Disorder*/drug therapy

  • Source: Psychiatry research [Psychiatry Res] 2024 Jun; Vol. 336, pp. 115907. Date of Electronic Publication: 2024 Apr 07.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Ireland NLM ID: 7911385 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Informed Consent to Psychedelic Treatment-A Work in Progress.

  • Authors : Appelbaum PS; New York State Psychiatric Institute, Columbia University, New York.

Subjects: Hallucinogens*/Hallucinogens*/Hallucinogens*/adverse effects ; Hallucinogens*/Hallucinogens*/Hallucinogens*/administration & dosage ; Informed Consent*

  • Source: JAMA psychiatry [JAMA Psychiatry] 2024 Jun 01; Vol. 81 (6), pp. 543-544.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.

  • Authors : Aaronson ST; Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, Maryland.; van der Vaart A

Subjects: Psilocybin*/Psilocybin*/Psilocybin*/therapeutic use ; Psilocybin*/Psilocybin*/Psilocybin*/adverse effects ; Psilocybin*/Psilocybin*/Psilocybin*/pharmacology

  • Source: JAMA psychiatry [JAMA Psychiatry] 2024 Jun 01; Vol. 81 (6), pp. 634.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Structural pharmacology and therapeutic potential of 5-methoxytryptamines.

  • Authors : Warren AL; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Lankri D

Subjects: Hallucinogens*/Hallucinogens*/Hallucinogens*/pharmacology ; Hallucinogens*/Hallucinogens*/Hallucinogens*/chemistry ; Receptor, Serotonin, 5-HT1A*/Receptor, Serotonin, 5-HT1A*/Receptor, Serotonin, 5-HT1A*/metabolism

  • Source: Nature [Nature] 2024 Jun; Vol. 630 (8015), pp. 237-246. Date of Electronic Publication: 2024 May 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Therapeutic Psilocybin's Adverse Effects Mostly Resolved Within 2 Days.

Subjects: Psilocybin*/Psilocybin*/Psilocybin*/adverse effects ; Psilocybin*/Psilocybin*/Psilocybin*/therapeutic use ; Hallucinogens*/Hallucinogens*/Hallucinogens*/adverse effects

  • Source: JAMA [JAMA] 2024 May 28; Vol. 331 (20), pp. 1699.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  8,702 results for ""Hallucinogens""